Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer

Cancer Genetics and Cytogenetics

Volumn 94, Issue 2, 1997, Pages 120-124

  Paz y Miño, César ^b   Peñaherrera, Ma Serena ^a   Sánchez, Ma Eugenia ^a   Córdova, Augusta ^a   Gutiérrez, Sara ^a   Ocampo, Ligia ^b   Leone, Paola E ^a  

^a Lab Genet Molec/Citogenetica Hum   (Ecuador)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME FRAGILITY; CHROMOSOME LOSS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; PLOIDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; APHIDICOLIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME FRAGILITY; CHROMOSOMES; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; ENZYME INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 0343035597     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00216-6     Document Type: Article

References (33)

1. INEC (1993): Anuario de estadisticas vitales. Nacimientos y defunciones. Instituto Ecuatoriano de Estadisticas y Censos, Quito, Ecuador.
2. SOLCA (1992): National Cancer Registry. Sociedad de Lucha contra el Cáncer. SOLCA, Quito, Ecuador.
3. Thompson M, Mclnnes R, Willard H (1991): Genetics in Medicine. W.B. Saunders Company, Philadelphia, USA.
4. Vernole P, Tedeschi B, Caporossi D, Nicoletti B (1988): A study on lymphocytes of neuroblastoma patients. Cancer Genet Cytogenet 36:13-23.
5. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia. Elsevier Science Publishing Co, New York, USA.
6. Vernole P, Tedeschi B, Nicoletti B (1990): Fragile site induction by aphidicolin may be increased in parents of neuroblastoma patients. Cancer Genet Cytogenet 50:35-44.
7. Ardisia C, Venti G, Colozza MA, Breschi C, Porfirio B, Davis S, Tonato M, Donti E (1993): Expression of aphidicolin induced fragile sites in lymphocytes of patients with breast cancer. Cancer Genet Cytogenet 67:113-116.
8. Le Beau M, Rowley J (1984): Heritable fragile sites in cancer. Nature 308:607-608.
9. Yunis J, Soreng AL (1984): Constitutive fragile sites and cancer. Science 226:1199-1204.
10. De Braekeleer M, Smith B, Lin C (1985): Fragile sites and structural rearrangements in cancer. Hum Genet 69:112-116.
11. Hecht F, Glover TW (1984): Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185-188.
12. Hecht F, Hecht BK (1984): Autosomal fragile sites and cancer. Am J Hum Genet 36:718-720.
13. Baumstark C (1992): Effect of aphidicolin on DNA synthesis and repair of human diploid fibroblasts. Int J Radiat Biol 61:191-197.
14. Mirazayans R, Dietrich K, Paterson M (1993): Aphidicolin and l-α-D-arabinofuranosylcytosine strongly inhibit transcriptionally active DNA repair in normal human fibroblasts. Carcinogenesis 12:26231-2626.
15. Glover T, Berger C, Coyle J, Echo B (1984): DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks on common fragile sites in human chromosomes. Human Genet 67:136-142.
16. ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature, F. Mitelman (ed.). Karger, Basel.
17. Sherman CD, Hossfeld DK (1992):20Cancer de Mama. In: Manual de Oncolgia Clinica, Estapé J, Hossfeld DK, Sherman CD, Low RR, Bosch FX, eds. Ediciones Doyma, S.A., Barcelona, pp. 271-291.
18. Donegan W, Spratt J (1982): Cancer de Mama. Editorial Medica Panamericana, Buenos Aires, Argentina.
19. De Waard F (1969): The epidemiology of breast cancer: Review and projects. Int J Cancer 4:577.
20. Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P (1987): High correlation between molecular alterations of the c-myc oncogne and carcinoma of the uterine cervix. Cancer Res 47:4173-4177.
21. McVie JG, Hossfield DK (1992): Tumores Ginecológicos. In: Manual de Oncolgia Clinica, Estapé J, Hossfeld DK, Sherman CD, Lowe RR, Bosch FX, eds. Ediciones Doyma S.A., Barcelona, pp. 292-299.
22. Rose DP (1992): Dietary Fiber, Phytoestrogens, and Breast Cancer. Nutrition 8 (No. 1): 47-51.
23. González TW (1974): El cuello uterino. In: Anatomia, Patologia, Citologia y Colposcopia, Márquez M, Casonova L. Puig-Tintoré LM, Lejáregui JA, Ausin J, Eds. Salvat Editores S.A., Barcelona, pp. 56-65.
24. Nakazawa A, Inoue M, Fujita M, Tanizawa O, Hakura A (1991): Detection of human papillomavirus type 16 in sexual partners of patients having cervical cancer by polymerase chain reaction. Jpn J Cancer Res 82:1187-1990.
25. Barrios L, Caballin MR, Miró R, Fuster C, Guedea F, Subias A, Egozcue J (1991): Chromosomal instability in breast cancer patients. Hum Genet 88:39-41.
26. Murty VVVS, Mitra AB, Luthra UK (1985): Spontaneous chromosomal aberrations in patients with precancerous and cancerous lesions of the cervix uteri. Cancer Genet Cytogenet 17:347-354.
27. Mitchell E, Woodhouse B, Birch JM, Santibanez-Koref M (1993): The expression of aphidicolin-induced fragile sites in familial breast cancer patients. Cancer Genet Cytogenet 67: 108-112.
28. Lönn U, Lönn S (1983): Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates. Cell Biol 80:3996-3999.
29. Reidy JA (1988): Aphidicolin, DNA repair, and fragile sites. Hum Genet. 78:198.
30. Geleick D, Muller H, Matter A, Torhost J, Regenass U (1990): Cytogenetics of breast cancer. Cancer Genet Cytogenet 46: 217-229.
31. Larsson C, Bystrom C, Skoog L, Rotstein S, Nordenskjold M (1990): Genomic alterations in human breast carcinomas. Genes Chromosom Cancer 2:191-197.
32. Atkin NB, Baker MC (1982): Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. Cancer Genet Cytogenet 7:209-222.
33. Sreekantaiah C, Bhargava MK, Shetty NJ (1988): Chromosome 1 abnormalities in cervical carcinoma. Cancer 62:1317-1324.